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Abstract. 
 
Hepatocyte growth factor (HGF) and EGF 
have been reported to promote branching morphogen-
esis of mammary epithelial cells. We now show that it is 
epimorphin that is primarily responsible for this phe-
nomenon. In vivo, epimorphin was detected in the stro-
mal compartment but not in lumenal epithelial cells of 
the mammary gland; in culture, however, a subpopula-
tion of mammary epithelial cells produced significant 
amounts of epimorphin. When epimorphin-expressing 
epithelial cell clones were cultured in collagen gels they 
displayed branching morphogenesis in the presence of 
HGF, EGF, keratinocyte growth factor, or fibroblast 
growth factor, a process that was inhibited by anti-epi-
morphin but not anti-HGF antibodies. The branch 
length, however, was roughly proportional to the ability 
of the factors to induce growth. Accordingly, epimor-
phin-negative epithelial cells simply grew in a cluster in 
response to the growth factors and failed to branch. 
When recombinant epimorphin was added to these col-
lagen gels, epimorphin-negative cells underwent 
branching morphogenesis. The mode of action of epi-
morphin on morphogenesis of the gland, however, was 
dependent on how it was presented to the mammary 
cells. If epimorphin was overexpressed in epimorphin-
negative epithelial cells under regulation of an induc-
ible promoter or was allowed to coat the surface of 
each epithelial cell in a nonpolar fashion, the cells 
formed globular, alveoli-like structures with a large 
central lumen instead of branching ducts. This process 
was enhanced also by addition of HGF, EGF, or other 
growth factors and was inhibited by epimorphin anti-
bodies. These results suggest that epimorphin is the pri-
mary morphogen in the mammary gland but that 
growth factors are necessary to achieve the appropriate 
cell numbers for the resulting morphogenesis to be vi-
sualized.
 
D
 
ynamic 
 
and reciprocal communication between ep-
ithelial and stromal compartments is a critical
component of epithelial morphogenesis (Grobstein,
1953; Spooner and Wessells, 1970; Kratochwil, 1983; Sax-
sen and Sariola, 1987; Sakakura, 1991). Recombination ex-
periments of stromal and epithelial tissues from different
origin have indicated that the stroma can dictate both the
growth of epithelia and the resulting morphological pat-
tern. For instance, salivary epithelium that was combined
with mammary stroma developed a mammary-like ductal
tree system, and mammary epithelium combined with sali-
vary mesenchyme developed a salivary gland-like pattern
(Sakakura et al., 1976). Attempts to understand the under-
lying molecular mechanism have identified morphoregula-
tory molecules that are preferentially expressed by the
stroma. These include cell surface molecules such as nerve
growth factor receptor and the ganglioside GD-3 (Sariola
et al., 1988, 1991), extracellular matrix (ECM)
 
1
 
 molecules
such as nidogen/entactin and tenascin (Ekblom et al., 1994;
Young et al., 1994) and growth factors such as hepatocyte
growth factor (HGF)/scatter factor (Montesano et al.,
1991
 
b
 
; Soriano et al., 1995), neu differentiation factor/he-
regulin (HRG) (Yang et al., 1995), and keratinocyte growth
factor (KGF)/FGF-7 (Simonet et al., 1995). Recently HGF
has emerged as an ubiquitous and central regulator of epi-
thelial morphogenesis in various tissues, including the
mammary gland (Brinkmann et al., 1995). Synthesis of
HGF by the stroma of the mammary gland is developmen-
tally regulated during ductal and alveolar branching mor-
phogenesis in puberty and pregnancy, whereas HGF re-
ceptor c-met is expressed by the epithelium throughout
development (Yang et al., 1995). EGF has been shown
also to be a potent morphogen in the mammary gland
 
1. 
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(Tonelli and Sorof, 1980; Coleman et al., 1988). In contrast
to HGF, EGF and its receptor are expressed by both epi-
thelial and stromal cells and also participate in regulation
of both ductal and alveolar morphogenesis (Snedeker et al.,
1991).
Epimorphin was isolated as a stromal protein mediating
morphogenesis of embryonic skin and lung (Hirai et al.,
1993). Epimorphin is a member of a gene family that com-
prises SED5, Pep12, Sso1p, Sso2p, and syntaxins 1A
(HPC-1), 1B, and 3-5 (Pelham, 1993). Members of this
family were shown to be involved in vesicle trafficking be-
tween Golgi, endoplasmatic reticulum, and plasma mem-
brane and lack a signal peptide for secretion. Nevertheless,
some antibodies to syntaxin 1A react with living cultured
cells (Inoue et al., 1992) and syntaxin 1B functions as a
glutamic acid receptor at the cell surface in addition to its
intracellular function (Smirnova et al., 1993
 
a
 
,
 
b
 
). Analo-
gous to syntaxin 1A and B, epimorphin is localized both in
the cytoplasm and at the extracellular surface of the plasma
membrane (Hirai, 1994; Butt et al., 1996). Some isoforms
of epimorphin might be anchored in the plasma mem-
brane by a putative membrane-spanning region, the ex-
pression of which is modulated by alternative splicing (Ben-
nett et al., 1993; Hirai, 1993). Other forms of this molecule
are generated by intermolecular interactions within the
coiled-coil domains of epimorphin giving rise to dimers
and tetramers (Yoshida et al., 1992; Hirai, 1994). The lat-
ter are preferentially expressed on the cell surface, whereas
the epimorphin monomer is most abundant in the cyto-
plasm. The existence of both intracellular and extracellu-
lar forms of epimorphin raises the question of whether
epimorphin affects epithelial morphogenesis by modulat-
ing the secretion of stromal morphregulatory molecules,
or through interaction of extracellular epimorphin with
epithelial cells.
To understand the role of extracellular epimorphin in
morphogenesis of the mammary gland in the context of a
microenvironment containing growth factors and stromal
collagen, we analyzed its effect on morphological differen-
tiation of mammary epithelial cells embedded in collagen
gels. We show here that it is epimorphin that acts as a key
morphoregulatory molecule for mammary epithelial cells,
and that HGF, EGF, and other growth factors assist in epi-
morphin-dependent morphogenesis, approximately pro-
portional to their growth-stimulating activity.
 
Materials and Methods
 
Cells
 
The functionally normal and nontumorigenic mouse mammary epithelial
cell lines CID-9 (Schmidhauser et al., 1990), SCp2 (Desprez et al., 1993)
and EpH4 (a gift from Dr. Reichmann, Institute Suisse de Recherches,
Switzerland; Reichmann et al., 1989; Brinkmann et al., 1995) were main-
tained in DME/F12 supplemented with 5% heat-inactivated FCS, 5 
 
m
 
g/ml
insulin (Sigma Chemical Co., St. Louis, MO) and 50 
 
m
 
g/ml gentamicin
(Life Technologies, Ltd., Paisley, Scotland; growth medium). For genera-
tion of SCp2 and EpH4 cell lines overexpressing extracellular epimorphin
under control of a tetracycline-regulated promoter, the signal peptide se-
quence of interleukin-2 (ATGTACAGCATGCAGCTCGCATCCTGT-
GTCACATTGACACTTGTGCTCCTTGTCAACAGCGCTCCC) was con-
nected to the NH
 
2
 
 terminus of a cDNA coding for full length epimorphin
isoform I (Hirai et al., 1992) and cloned into the HindIII restriction site of
the eukaryotic expression vector pTeT-splice (Life Technologies, Ltd.).
Cells (5 
 
3
 
 10
 
5
 
) were transfected with 5 
 
m
 
g of the above construct, 5 
 
m
 
g of
pTet.tTAK vector (Life Technologies, Ltd.) coding for the tTAK protein,
which suppresses transcription of the transgene in the presence of tetracy-
cline, and 0.5 
 
m
 
g of pSV40neo containing a neomycin resistance cassette
(Schmidhauser et al., 1992) in 1 ml of Opti-MEM (Life Technologies,
Ltd.) using Lipofectin (Life Technologies, Ltd.), according to the manufac-
turer’s instructions. After selection of neomycin resistant clones in the con-
tinuous presence of tetracycline, the expression of epimorphin was ana-
lyzed by Western blotting, in the presence and absence of 5 
 
m
 
g/ml
tetracycline. PTSEd and PTSEe, which expressed epimorphin transgene
after removal of tetracycline from the culture medium, and PTSEa and
PTSEb, which did not express epimorphin with and without tetracycline,
were isolated from SCp2 cells; ETSEII, which inducibly expressed exoge-
nous epimorphin, was isolated from the epimorphin-negative population
of EpH4 cells.
 
Generation of Recombinant Epimorphin
 
Recombinant full-length epimorphin (H123) is identical to endogenous
epimorphin lacking membrane-spanning region and represents all iso-
forms (see Fig. 3 
 
A
 
). Recombinantly generated epimorphin fragments H2
and H13 represent the cellular recognition domain of epimorphin (amino
acids 104–187) and a fusion of NH
 
2
 
- (amino acids 1–103) and COOH-
(amino acids 188–264) terminal coiled-coil domains of epimorphin, respect-
ively. They were tagged with six histidine residues, expressed in 
 
Escherichia
coli
 
 and purified over Ni columns in the presence of urea as described
(Oka and Hirai, 1996). Urea was necessary, since all recombinant prod-
ucts precipitated immediately upon removal of urea under the neutral pH.
For use in cell culture, recombinant epimorphin was dialyzed against 1.5 mM
HCl and filtered under sterile conditions.
 
Antibodies
 
Affinity-purified antibodies to epimorphin were prepared as follows: rab-
bit antiserum against untagged recombinant epimorphin (Hirai, 1994) was
mixed with an equal volume of PBS, pH 7.4, precipitated with 40% ammo-
nium sulfate, dissolved in PBS, and dialyzed against PBS. Subsequently, anti-
bodies were adsorbed to nitrocellulose membranes (Millipore Corp., So.
San Francisco, CA) precoated with 1 mg/ml histidine-tagged epimorphin by
incubation for 4 h at ambient temperature. After several washes with PBS,
antibodies bound to recombinant epimorphin were eluted with 0.25 M
glycine-HCl, pH 2.7. Affinity-purified anti-epimorphin antibody was im-
mediately neutralized with 1 M phosphate buffer, pH 8.0, precipitated
with 60% ammonium sulfate and dissolved in DME/F12 (Life Technolo-
gies, Ltd.). Epimorphin antibodies were then dialyzed against DME/F12
and filtered under sterile conditions. Purified rabbit IgG (DAKO Corp.,
Glostrup, Denmark) were dialyzed against DME/F12, sterile filtered, and
used as the control.
Mouse anti-vimentin, mouse anti–
 
a
 
-smooth muscle actin, FITC-conju-
gated sheep anti–mouse IgG, and rhodamine-conjugated goat anti–rabbit
IgG antibodies were purchased from Sigma Chemical Co. FITC-conju-
gated goat anti–rat IgG antibodies were from Caltag Labs (So. San Fran-
cisco, CA). HRP-conjugated donkey anti–rabbit Ig antibodies were from
Amersham Corp. (Buckinghamshire, U.K.). Function blocking anti-HGF
antibodies were from Sigma Chemical Co. Rat monoclonal antibody
against E-cadherin, ECCD2 (Shirayoshi et al., 1986), was a generous gift
from Dr. Takeichi (Kyoto University, Japan).
 
Cell Attachment and Proliferation Assays
 
Cell attachment assays were carried out as previously described (Oka and
Hirai, 1996), with minor modifications. In brief, each well of 24-well plates
(nontreated for cell culture; Falcon, Becton Dickinson Labware, Franklin
Lakes, NJ), was coated with 5 
 
m
 
g/cm
 
2
 
 of recombinant epimorphin (H123),
epimorphin fragments H2 or H13 in 1.5 mM HCl, and subsequently air
dried. Cells (2 
 
3
 
 10
 
4
 
) were plated in DME/F12 medium containing 4 mg/
ml of BSA onto epimorphin-coated substrata and incubated at 37
 
8
 
C. Anti-
epimorphin antibodies and control antibodies, at a total concentration of
20 
 
m
 
g/ml, were added to medium. After an 8-h incubation, plates were
tapped sharply and washed twice with PBS. Cells bound to the plates were
then detached after trypsinization and counted. Wells uncoated and
coated with 5 
 
m
 
g/cm
 
2
 
 type I collagen (Cellagen™ ; ICN, Irvine, CA) in 1.5
mM HCl were used as negative and positive controls. All experiments
were conducted in duplicate and repeated three times.
For proliferation assays, cells (1 
 
3
 
 10
 
5
 
) were seeded into each well of 
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12-well plates coated with epimorphin fragments, as described above. Af-
ter 8 h of incubation, replicate cultures of attached cells were washed, de-
tached, and counted (N
 
0
 
). Cells attached in similar numbers regardless of
whether wells were precoated with H123, H2, or collagen type I. Growth
medium was added to remaining wells and incubated for an additional 2 d.
After such time, cell number was determined (N
 
2
 
) and growth ratio (N
 
2
 
/
N
 
0
 
) was calculated. The proliferation assay was also carried out in the
presence of 50 ng/ml recombinant HGF (Becton Dickinson, Bedford, MA)
or 50 ng/ml EGF (Sigma Chemical Co.). The proliferation assays were
performed in duplicate and repeated three times.
To measure the effects of HGF, EGF, KGF, and FGF on proliferation
of cell clusters in collagen gels (see three-dimensional cultures, below),
the diameters of 
 
.
 
50 cell clusters cultured for 8 d with one of these growth
factors (50 ng/ml) were measured and compared to those of control.
 
Preparation of Cell Clusters
 
The cell clusters were prepared as follows: agarose was heated in PBS (fi-
nal 2%) and 250 
 
m
 
l of the solution was added to each well of 24-well
plates. After the agarose gelled, 1.5 ml of growth medium was added to
each well and incubated for 30 min at 37
 
8
 
C in CO
 
2
 
 incubator. This me-
dium was then discarded and 5 
 
3
 
 10
 
4
 
 cells, suspended in 500 
 
m
 
l of growth
medium containing 1,000 U of desoxyribonuclease I (DNase I; Sigma
Chemical Co.), were seeded on top of the agarose gel and incubated with
gentle rotation (100 rpm) for 24 h at 37
 
8
 
C. After incubation, cells formed
smoothly rounded and well packed clusters of 150 to 250 
 
m
 
m diam. The
remaining single cells were removed by centrifugation for 30 s at 200 rpm.
To obtain clusters of primary mammary cells, a cell suspension of glands
from 12 to 15 d pregnant mice was prepared as follows: the glands were
minced with a sharp razor blade and incubated with 0.2% trypsin (Life
Technologies, Ltd.) and 0.2% collagenase I (Life Technologies, Ltd.) in
DME/F12 with agitation (100 rpm) for 30 min at 37
 
8
 
C, followed by centri-
fugation at 1,000 rpm for 3 min. After discarding the fat-containing super-
natant, cells in the pellet were resuspended in growth medium supple-
mented with 1,000 U of DNase I and incubated for 2 min. Cells were then
washed three times with growth medium.
 
Three-Dimensional Cultures
 
For three-dimensional cell cultures, cell clusters were embedded in type I
collagen gels. The embedding process into collagen gels was similar to that
described for single cells by Montesano et al. (1991
 
a
 
). Acid-soluble col-
lagen (7.5 vol of a 0.5% solution; Cellagen™ AC-5; ICN) was mixed gen-
tly on ice with 1 vol of 1.5 mM HCl (blank solution) and 1 vol of 10
 
3
 
 DME/
F12, followed by mixing with 0.5 vol of alkaline solution to neutralize the
pH. After adding 1:20 vol of FCS, 250 
 
m
 
l of the collagen solution was
poured into each well of a 24-well dish, and the dish was incubated at 37
 
8
 
C
to allow gelation of the basal collagen layer. The cell clusters were sus-
pended in growth medium at a concentration of 2,500 to 4,000 clusters/ml,
and 10 
 
m
 
l of the suspension (25–40 clusters) was mixed with 250 
 
m
 
l of ice-
cold collagen solution, poured onto the basal collagen layer, and placed
immediately at 37
 
8
 
C. To prepare collagen substrate containing recombi-
nant epimorphin or control peptides, one vol of a 1 mg/ml stock solution
of H123 or its fragments (H2 or H13) in 1.5 mM HCl was used instead of
the blank solution. To prepare cell clusters in which recombinant epimor-
phin were present around each cell, cells were precultured on H123- or
H2-coated plates for 4 d, as described in Cell Attachment and Prolifera-
tion Assay before making clusters (see Fig. 7 
 
B
 
). After gelation of col-
lagen, 500 
 
m
 
l of growth medium was added to each well. Medium was
exchanged every 5 d. HGF, EGF, KGF (Sigma Chemical Co.), or bFGF
(Sigma Chemical Co.) were added to replicate wells at a concentration of
50 ng/ml. Blocking antibodies to epimorphin, HGF (Sigma Chemical Co.)
or control antibodies were added to replicate wells at a concentration of
100 
 
m
 
g/ml.
 
Analysis of the Morphogenic Phenotypes of
Cell Clusters
 
The phenotype of cell clusters embedded in collagen gels was determined
after cultivation for 8 d. A cluster was defined as a “branching” phenotype
if it had at least three independent extending cell processes that were
longer than the diameter of the cell cluster. A cluster was defined as a “lu-
menal” phenotype if it had a clearly visible lumen occupying 
 
.
 
50% of the
volume of cluster. There were few clusters that had the double phenotype;
these were scored in each category. The quantification of the phenotypic
appearance was carried out by counting the percentage of a particular
phenotype from at least 50 randomly selected clusters in each experiment.
The experiments were repeated at least three times.
 
Western Blotting and Immunohistochemistry
 
Western blotting for detection of epimorphin was carried out as described
previously (Hirai, 1994). In brief, cells were lysed with Laemmli sample
buffer (Laemmli, 1970), and proteins were separated on 4 to 20% SDS–
polyacrylamide gradient gels and subsequently blotted onto polyvinylli-
dene difluoride membranes (Immobilon P; Millipore Corp.). Membranes
were then washed with TBS (50 mM Tris, pH 7.5, 100 mM NaCl), and
treated successively with 5% skim milk in TBS (STBS) for 1 h, 1:150 diluted
anti-epimorphin antibodies in STBS for 1 h and 1/1,000 diluted HRP-
labeled anti–rabbit antibodies in STBS for an additional hour, with exces-
sive washing with TBS in each interval. Labeled epimorphin was visual-
ized with enhanced chemiluminescence (ECL) reagent (Amersham Corp.)
according to the manufacturer’s instructions.
Immunohistochemistry was carried out as described previously (Oka
and Hirai, 1996). In brief, 10-
 
m
 
m cryosections of tissues or cell clusters
were treated successively with STBS, first antibody solution in STBS and
FITC-, rhodamine-, or HRP-labeled second antibody solution in STBS,
with excessive washing with TBS in each interval. To visualize HRP-
labeled epimorphin, sections were treated with 0.69 mM 3,3
 
9
 
-diaminoben-
zidine (Sigma Chemical Co.) and 0.3 mM H
 
2
 
O
 
2
 
 dissolved in TBS. Sections
were counterstained with 4,6-diamidino-2-phenyl-indole (DAPI; Sigma
Chemical Co.) or hematoxylin (Sigma Chemical Co.). Antibodies to epi-
morphin, vimentin, 
 
a
 
-smooth muscle actin, or E-cadherin (ECCD-2) were
diluted to 1:100, 1:100, 1:300, or 1:300, respectively, and used for primary
antibody treatment. The FITC-, rhodamine-, or HRP-labeled secondary
antibodies to rabbit, mouse, and rat Ig were diluted to 1:150.
 
Results
 
Localization of Epimorphin in the Mouse Mammary 
Gland and in Mouse Mammary Cell Lines
 
In fetal skin, lung, and submandibular gland, epimorphin
expression is restricted to the stromal tissue compartment
(Hirai et al., 1992; Kadoya et al., 1995). In the postnatal
mammary gland, epimorphin was detected between fibro-
blasts and adipocytes and around ducts and alveoli in vir-
gin, pregnant, and lactating mice (Fig. 1 
 
A
 
). The pattern of
immunostaining suggested that epimorphin was not ex-
pressed by lumenal epithelial cells, but by fibroblasts and
possibly by myoepithelial cells. Indeed, when isolated cells
from the mammary gland were examined for epimorphin
expression, only fibroblasts and some myoepithelial cells,
but not lumenal epithelial cells, were stained for epimor-
phin, as determined by double labeling of cells with anti-
bodies to epimorphin and E-cadherin, 
 
a
 
-smooth muscle
actin, and vimentin, markers for, respectively, lumenal ep-
ithelial cells (Daniel et al., 1995), myoepithelial cells
(Deugnier et al., 1995), and fibroblasts (Dulbecco et al.,
1983) (Fig. 1 
 
B
 
). To ascertain whether epimorphin was
present extracellularly at the surface of mammary cells,
anti-epimorphin antibodies were added to clusters of liv-
ing primary mammary cells for 2 h on ice, washed several
times with growth medium, and embedded for cryosections.
As a negative (intracellular) control for this assay, anti-
vimentin antibodies and FITC-labeled anti–mouse Ig were
mixed with anti-epimorphin antibodies and rhodamine-
labeled anti–rabbit Ig, respectively. Labeling of the living
cells with anti-epimorphin antibodies demonstrated that
epimorphin was present also extracellularly (Fig. 1 
 
B
 
, 
 
d
 
).
We then examined expression of epimorphin in three
mouse mammary epithelial cell lines, CID-9, SCp2, and 
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EpH4, that have been used previously to study tissue-spe-
cific gene expression and morphogenesis of mammary epi-
thelial cells in culture (Schmidhauser et al., 1990; Desprez
et al., 1993; Brinkmann et al., 1995). In CID-9 cells, which
consist of both epithelial and “fibroblastic” cells (Schmid-
hauser et al., 1990; Desprez et al., 1993), all vimentin-express-
ing cells were epimorphin positive (Fig. 2, 
 
a–c
 
), in agree-
ment with our observations with primary cells isolated
from the mammary gland (Fig. 1 
 
B
 
). However, a minority
of vimentin-negative cells also expressed epimorphin. This
was also the case for SCp2, a clonal epithelial cell line de-
rived from CID-9 (Desprez et al., 1993) and especially for
EpH4, an independent cell line isolated by Reichmann et
al. (1989). Although neither cell line expressed vimentin,
60–70% of EpH4 and 
 
z
 
5% of SCp2 cells expressed epi-
morphin (Fig. 2, 
 
d–i
 
). Epimorphin-expressing SCp2 and
EpH4 cells were cytokeratin and E-cadherin positive but
did not express 
 
a
 
-smooth muscle actin (not shown), indi-
cating that some lumenal epithelial cells do turn on epi-
morphin gene expression in culture.
 
Effect of Epimorphin on Attachment and Proliferation 
of Mammary Epithelial Cells
 
Given that mammary lumenal epithelial cells in vivo do
not express epimorphin but are surrounded by epimor-
phin-positive cell populations, one could postulate the ex-
istence of epimorphin receptors (not yet characterized) if
epimorphin were to act directly on epithelium. We asked
whether mammary epithelial cells in culture can interact with
epimorphin. Since SCp2 cells were largely devoid of en-
dogenous epimorphin, as are mammary epithelial cells in
vivo (Fig. 2, 
 
g–i
 
), these cells were tested for their ability to
bind to purified recombinant epimorphin (Fig. 3). About
80% of plated SCp2 cells attached to substratum-bound
recombinant epimorphin within 8 h (Fig. 4, 
 
A
 
 and 
 
B
 
). At-
tachment of cells to epimorphin was as efficient as their at-
tachment to type I collagen. As was shown previously for
endothelial cells (Oka and Hirai, 1996), cells attached to
the H2 cell-binding domain of epimorphin and to full-length
epimorphin H123 but not to the coiled-coil domain H13
(Fig. 4 
 
B
 
). Binding of cells to epimorphin-coated plates
could be inhibited with anti-epimorphin antibodies in a
dose-dependent fashion, whereas binding to type I col-
lagen could not. These observations suggest that SCp2
cells can interact with extracellularly presented epimorphin.
When cells were maintained in the presence of serum-
containing medium, substratum-bound epimorphin H123,
but not its cell-binding H2 domain alone, slightly inhibited
proliferation of SCp2 cells (Fig. 4 
 
C
 
), as was seen previ-
Figure 1. Expression of epimorphin in the mammary gland. (A)
Localization of epimorphin in the sections of glands from virgin
(a and b), mid-pregnant (c), and lactating (d) CD-1 mice. The area
boxed in black in a is shown at higher magnification in b. (B) De-
tection of epimorphin-producing cell types. Frozen sections of
mammary glands from mid-pregnant mice were immunostained
with anti-epimorphin antibodies and rhodamine-labeled second-
ary antibodies (red). Sections were also stained for E-cadherin
(a), a-smooth muscle actin (b), or vimentin (c) using their specific
antibodies and FITC-labeled secondary antibodies (green). Nu-
clei were visualized with DAPI (blue). (d) Living cells were
treated with a mixture of anti-epimorphin and anti-vimentin anti-
bodies, and labeled antibodies were visualized with rhodamine-
(for epimorphin) and FITC- (for vimentin) labeled secondary an-
tibodies. Note that both anti-epimorphin and vimentin antibodies
stained sections (c), but only the former labeled the living cells,
indicating epimorphin is localized also at the cell surface (d).
Bars, 120 mm.
Figure 2. Expression of epimorphin in epithelial model cells. Sec-
tions of cell clusters of CID-9 (a–c), EpH4 (d–f), and SCp2 (g–i)
were stained simultaneously for epimorphin (a, d, and g), vimen-
tin (b, e, and h), and DAPI (c, f, and i). *, epimorphin-negative
subpopulation of EpH4. Note that 30–40% of CID-9 cells and
60–70% of EpH4 cells expressed epimorphin. Almost all SCp2
cells were negative for epimorphin but a minor subpopulation
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ously in endothelial cells (Oka and Hirai, 1996). When HGF
or EGF were added to the culture medium, cells overcame
the inhibitory effects of epimorphin and continued to grow
(Fig. 4 C).
Effect of Epimorphin on Branching Morphogenesis of 
Mammary Epithelial Cells
To analyze the effect of epimorphin on morphogenesis of
mammary epithelial cells, clustered SCp2 cells were em-
bedded in collagen gels containing recombinant epimor-
phin. Cell clusters rather than individual cells were used in
this assay because of epimorphin’s growth inhibitory effect
(Fig. 4 C).
As shown in Fig. 5, A and B, z20% of cell clusters of
SCp2 cells exhibited branching morphogenesis in the pres-
ence of epimorphin (H123), compared to z5% in the ab-
sence of epimorphin. HGF, in the absence of epimorphin,
accelerated growth but had no effect on morphogenesis of
SCp2 cells (Fig. 5 A, d, and B). However, the percentage
of cell clusters undergoing visible branching morphogene-
sis was markedly increased to 80% when cells were stimu-
lated by both epimorphin and HGF. The H2 cell-binding
domain of epimorphin alone was insufficient to induce
branching morphogenesis (Fig. 5 B). We asked whether or
not HGF was necessary or whether another growth factor
could replace its branching function. EGF, KGF, and FGF
also promoted growth of SCp2 cell, and morphogenesis
was stimulated only when epimorphin was also present
(Fig. 5, C and D). The branch length was roughly propor-
tional to the ability of the factor to induce growth (Fig. 5,
C and D). Anti-HGF function-blocking antibodies did not
prevent branching if HGF was replaced by EGF and if epi-
morphin was present. These observations demonstrate
that epimorphin positions the cells to undergo branching
morphogenesis in response to several growth factors.
To prove that epimorphin was indeed essential for branch-
ing morphogenesis of SCp2 cells, we isolated D6 and I6
cell lines, two clonal derivatives of the epimorphin-positive
subpopulation of SCp2 cells. These cells expressed both
epimorphin monomers comprised of 31 (isoform III) and
34 kD (isoform I and II; Hirai, 1993) and epimorphin
dimers and tetramers comprised of z70 and 150 kD (Hi-
rai, 1994), respectively (Fig. 6 A). When preclustered,
these cells expressed epimorphin surprisingly only at the
periphery of cell aggregates (Fig. 6 B), reminiscent of the
epimorphin staining pattern in the mammary gland around
ducts and alveoli (Fig. 1 A). Consistent with what was ob-
served in the mixed populations such as CID-9, this cell
type displayed branching morphogenesis in the presence
of growth factors without exogenously added epimorphin.
However, the extent of the branching could be increased
further by addition of epimorphin to the collagen gels (Fig.
6 C). The branching phenotype of D6 and I6 cells in the
presence of HGF was blocked by anti-epimorphin anti-
bodies (Fig. 6, C and D). On the other hand, cell clusters
isolated from the epimorphin-negative subpopulations could
not branch in the absence of exogenous epimorphin (Fig. 6
D). We therefore conclude that epimorphin is essential for
branching morphogenesis of mammary epithelial cells in
culture.
Pericellular Epimorphin Leads to “Lumen” Formation 
Instead of Branching Morphogenesis
In the experiments described above, cells were in contact
with epimorphin only at the periphery of cell clusters even
in the case of epimorphin-positive D6 and I6 cells, where
the center of the cluster was negative. This suggests that
polarized presentation of epimorphin at the basal cell sur-
Figure 3. Preparation of recombinant epimorphin. (A) Schematic
diagram of epimorphin isoforms and the recombinant epimor-
phin fragments used in this study. There are three epimorphin
isoforms produced by alternative splicing. Isoforms I and II (34-kD
products) have a putative membrane-spanning region at the
COOH terminus, whereas isoform III (31-kD products) has not.
The recombinant epimorphin fragment H123 represents the epi-
morphin sequence shared by all the isoforms. H13 is a fusion pep-
tide of the NH2- and COOH-terminal coiled-coil domains of
H123, and H2 is a peptide of only the cellular recognition domain
inserted between the coiled-coil domains. *, NH2-terminally
tagged histidine residues. (B) Coomassie brilliant blue–stained
epimorphin fragments in SDS-PAGE gel.
Figure 4. Attachment and
proliferation of an epithelial
cell line on recombinant epi-
morphin. (A and B) Attach-
ment of SCp2 cells to sub-
strate-coated epimorphin
fragments. Cells bound to
each epimorphin fragment
in 8 h were photographed
(A) and quantified (B). Un-
coated (2) and collagen
type I–coated wells were
used as negative and positive
controls, respectively. Me-
dium contained mock anti-
bodies and anti-epimorphin
antibodies at a total concen-
tration of 20 mg/ml as indi-
cated. P values between 2
and H123 (mock Ab20), and
H123 (mock Ab20) and H123
(anti-EPM20) were ,0.0001.
(C) The growth ratios (cell
number in 2 d plus 8 h di-
vided by cell numbers 8 h after plating) of SCp2 cells cultured on
type I collagen, H123, and H2 fragments. HGF and EGF were
tested at 50 ng/ml. Significant inhibition of cell growth was ob-
served in cells cultured on H123 in the absence of additional
growth factors. *, P values versus H2 (2) and collagen (2) were
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face, where epithelial cells interact with the ECM, might
be important for establishment of ductal branching. To
find out what will happen if epimorphin was presented to
the cells in a nonpolar fashion, SCp2 cells were cultured on
epimorphin-coated plates for 4 d, trypsinized briefly, and
subsequently embedded into collagen gels after preclus-
tering. This treatment allowed all cells to be coated with
the otherwise insoluble epimorphin from the tissue culture
dish, since trypsin treatment does not remove all the re-
combinant epimorphin from the cells (Fig. 7 A). After pre-
clustering, recombinant epimorphin localized to both the
periphery and around each cell of the clusters (Fig. 7 B).
Once placed in collagen gels, z20% of SCp2 cell clusters
developed a “lumenal” phenotype characterized by large
globular structures that were devoid of branching ducts
(Fig. 7 C). As was the case with the branching phenotype,
the lumenal phenotype was dramatically enhanced in the
presence of HGF or EGF (Fig. 7 D; as well as KGF and FGF,
and it was roughly proportional to the growth factor’s abil-
ity to induce cell proliferation in collagen gels; not shown).
Thus when epimorphin is presented in a nonpolar fashion
around all the epithelial cell surface as a coating, it induces
lumen formation in place of branching morphogenesis.
Growth factors again simply enhance this phenotype.
To further confirm this finding, a cDNA coding for epi-
morphin connected to a signal peptide for secretion was
transfected into SCp2 cells, under the control of a tetra-
cyline-repressible promoter (Shockett et al., 1995). When
tetracycline was removed from the cell culture medium,
epimorphin, modified with N-linked glycosylation, was ex-
pressed uniformly on all the cell surfaces of the transfec-
tants PTSEd and PTSEe (Fig. 8, A and B). Induction of
epimorphin on a tissue culture substratum resulted in inhi-
bition of cell growth (Fig. 8 C) as observed also with exog-
enous epimorphin (Fig. 4 C). When cell clusters were em-
bedded into collagen gels and cultured in the presence of
Figure 5. Effect of recombi-
nant epimorphin and growth
factors on branching mor-
phogenesis of SCp2 cells. (A)
Morphology of SCp2 cell
clusters cultured for 8 d in
collagen gels mixed with (a
and b) or without (c and
d) recombinant epimorphin
H123. Presence of H123 in
substrate and outside the
clusters is indicated as
H123EX. HGF (50 ng/ml)
was added to the medium in
b and d. b9 and d9 are sec-
tions of b and d stained with
hematoxylin, respectively.
(B) Quantification of the
branching phenotype of
SCp2  cells depicted in A. Cell
clusters were surrounded by
H123, H2, or H13 in collagen
(indicated as H123EX, H2EX,
or H13EX, respectively). Note
that H123, but not H2 and
H13 fragments induced branch-
ing  morphogenesis in col-
lagen gels. HGF dramatically
enhanced the effect of H123
and functional blocking anti-
bodies to HGF (100 mg/ml)
completely neutralized HGF.
(C) Effect of other growth
factors on morphology of
SCp2 cell clusters. EGF (a, d,
and g), KGF (b and e), and
FGF (c and f) can also induce
branching morphogenesis in
the presence (a–c and g) but
not in the absence (a–c) of
epimorphin H123 (H123EX).
All of the factors were added to medium at 50 ng/ml. Note that EGF induced epimorphin-dependent branching morphogenesis even
in the presence of function-blocking anti-HGF antibodies. (D) Summary of above data. For growth in collagen, when the average diam-
eter of .50 clusters was 1–23 the control (size of cluster without the factor addition) and P value versus control was ,0.1, it was de-
noted 1; 2–33 the control is 11, and 33 or larger, 111. Branching was scored as described in Materials and Methods. Bars: (A and
C) 200 mm.Hirai et al. Epimorphin Is a Morphogen in the Mammary Gland 165
HGF, induction of the epimorphin transgene led to forma-
tion of large globular structures and little or no ductal
branching (Fig. 9 A), similar to the results obtained in the
preceding set of experiments (Fig. 7). Expression of epi-
morphin transgene in ETSEII cells, which were derived
from an epimorphin-negative subpopulation of another
mammary cell line EpH4, also led to lumen formation
(Fig. 9 B). Again, HGF could be replaced by EGF (not
shown), and anti-epimorphin antibodies could block this
type of morphogenesis as well (Fig. 9, A and B). These
data indicate that epimorphin, when expressed homoge-
neously on the entire cell surface, induces formation of
large spherical structures, whereas polarized presentation
of epimorphin results in formation of branching ducts.
Thus epimorphin dictates the mode of morphogenesis of
mammary epithelia depending on its localization, and growth
factors such as HGF and EGF assist in this process by
stimulation of cell proliferation.
Discussion
The importance of epimorphin in control of morphogene-
sis of mammary epithelia is supported by the following ob-
servations: first, morphogenesis of epimorphin-negative epi-
thelial cells was induced only by addition of epimorphin
but not by growth factors alone. Second, epimorphin could
Figure 6. Branching mor-
phogenesis of clonal deriva-
tives of SCp2 cells. (A) The
level of endogenous epimor-
phin in parental SCp2 and an
epimorphin-positive clonal
population (D6). Note that
only very faint bands of en-
dogenous epimorphin were
detected in the SCp2 cells, as
would be expected from the
immunofluorescence studies
(only z5% express epimor-
phin). (B) Detection of en-
dogenous epimorphin in the
clusters of SCp2 and D6 cells.
The sections of SCp2 (a and
c) and D6 (b and d) cells
were stained for epimorphin
(a and b) and DAPI (c and
d). The expression of epi-
morphin was still heteroge-
nous in D6 cells and only the
peripheral portion of the
clusters were epimorphin-
positive. (C) Appearance of
cell clusters of D6 cultured
for 8 d in collagen gels with
(c) or without (a and b) addi-
tional recombinant epimor-
phin H123, in the presence of
50 ng/ml HGF. Mock anti-
bodies (a and c) or anti-epi-
morphin antibodies (b) were
added to medium at 100 mg/
ml. c9 is a section of c stained
with hematoxilin. Note that
D6 demonstrated branching
morphogenesis in collagen,
but exogenous epimorphin
(H123EX) enhanced, and
anti-epimorphin antibodies
perturbed the phenotypic ap-
pearance. (D) Effect of H123
and anti-epimorphin anti-
bodies on the appearance of
branching phenotype of sev-
eral subclones derived from
SCp2. About 60% of D6 and
40% of I6 cells were epimorphin positive, whereas PTSEa and PTSEb (refer to Fig. 8) were epimorphin negative. The values indicate
mean 6 SD of three separate experiments. Bars: (B) 120 mm; (C) 200 mm.The Journal of Cell Biology, Volume 140, 1998 166
induce different patterns of morphological differentiation,
depending on the way it was presented to the cells. Third,
morphogenesis of epimorphin-expressing epithelial cells
was completely blocked by anti-epimorphin antibodies,
even in the presence of growth factors. And fourth, as long
as a growth factor could elicit growth from cells, it could
augment the morphogenesis, but it did not matter which
growth factor was used. Indeed, cells branched very well in
the presence of function blocking antibodies to HGF, if
epimorphin and another growth factor such as EGF were
present.
Epimorphin was present in the mammary gland of vir-
gin, pregnant, and lactating mice within the mesenchyme
and around ducts and alveoli. Isolation of mammary cells
revealed that epimorphin was produced not only by mesen-
chymal cells, but also by some myoepithelial cells, whereas
lumenal epithelial cells were epimorphin negative. These
data extend the previous observations made on mesen-
chymes prepared from skin, lung, and submandibular tis-
sues, where epimorphin is also synthesized primarily by
mesenchymal cells. The mouse mammary epithelial cell lines,
SCp2 and EpH4, used in our studies are lumenal epithelial
cells since they can produce milk proteins under appropri-
ate culture conditions (Reichmann et al., 1989; Desprez et al.,
1993); they also express cytokeratins and E-cadherin but
not the myoepithelial marker a-smooth muscle actin or
the mesenchymal marker vimentin (not shown). We found
that EpH4 cells and a small subpopulation of SCp2 cells
express epimorphin, suggesting that epimorphin expres-
sion in lumenal epithelial cells in vivo is suppressed by the
cellular microenvironment in the mammary gland. In fur-
ther support of our finding that epimorphin is required for
morphogenesis, clonal subpopulations of SCp2 cells that
expressed epimorphin branched upon exposure to growth
Figure 7. Nonpolar presence
of recombinant epimorphin
around each cell of the cluster
leads to “lumen” formation.
(A) Immunoblot detection of
recombinant epimorphin in
the clusters of SCp2 cells.
(Right lane) Clusters of SCp2
cells precultured on H123 for
4 d (SCp2H123IN). (Left
lane) Purified H123 (5 ng).
(B) Detection of recombi-
nant epimorphin (H123) in
the cell clusters. Sections of
the clusters were stained with
anti-epimorphin antibodies
(a) and with DAPI (b). (C)
Appearance of the clusters of
H123-containing SCp2 cells
(SCp2 H123IN) in collagen
gels, cultured for 8 d in the
absence (a) or presence (b)
of 50 ng/ml HGF. (D) Quan-
tification of the branching
and “lumenal” phenotype of
the clusters of SCp2. Clusters
of cells precultured on H123,
H2, or H13 are shown as
H123IN, H2IN, or H13IN,
respectively. Note that H123
but not H2 and H13 frag-
ments in the cluster induced
“lumen” formation. EGF as
well as HGF dramatically en-
hanced the effect of H123.
Bars: (B) 120 mm; (C) 200 mm.Hirai et al. Epimorphin Is a Morphogen in the Mammary Gland 167
factors, whereas epimorphin-negative cell clones did not.
This finding also provides an explanation for the perplex-
ing data where HGF induced branching morphogenesis in
some, but not all, of the mammary cell models examined
(Brinkmann et al., 1995; Soriano et al., 1995). Indeed, we
found that EpH4 cells, which were shown previously to
branch when HGF was added (Brinkmann et al., 1995),
were heterogeneous and contained epimorphin-expressing
cells that could signal to epimorphin-negative cells to un-
dergo growth factor–induced morphogenesis in the ab-
sence of exogenously added epimorphin. Accordingly, when
epimorphin-negative subclones were isolated they re-
quired exogenous epimorphin for branching morphogene-
sis. Interestingly, a study using primary lumenal epithelial
and myoepithelial cells from mouse and human mammary
gland concluded that HGF promoted branching morpho-
genesis only in myoepithelial cells (shown here to contain
epimorphin-positive cells) but not lumenal epithelial cells
which, as demonstrated here, are epimorphin negative in
vivo (Niranjan et al., 1995). Likewise, branching and alve-
olar morphogenesis in primary organoid cultures that con-
tain lumenal epithelial cells, myoepithelial cells and perhaps
some fibroblasts, are efficiently induced by growth factors
(Yang and Nandi, 1983; Darcy et al., 1995). Thus, all stud-
ies presented in the literature are compatible with our con-
clusion that epimorphin is indispensable for branching mor-
phogenesis of mammary epithelia.
In previous studies that analyzed morphogenesis of
mammary epithelia, proliferative influences were not dis-
tinguished from morphogenic effects. We found that HGF,
EGF, KGF, and FGF promoted growth but not morpho-
genesis of mammary epithelia in the absence of epimor-
phin. Epimorphin, on the other hand, had some inhibitory
influence on cell growth. Consequently, it was difficult to
visualize stimulation of morphogenesis by epimorphin in
the absence of growth factors. While epimorphin appears
to be present throughout the mammary gland develop-
ment, growth factor expression appears to be highest dur-
ing intense morphogenetic phases in vivo (Yang et al., 1995).
Thus, the coordinate expression of epimorphin and growth
factors is likely to dictate morphogenesis in the mammary
gland and possibly other organs, with one signaling com-
ponent (growth factors) triggering growth and another (epi-
morphin) triggering morphogenesis. The nature of the lat-
ter is determined by the localization and distribution of
epimorphin.
When epimorphin was presented at the periphery of ep-
ithelial clusters (at the border where epithelial cells con-
tact collagen in culture, and stroma in vivo), it induced
ductal branching; when epimorphin was accessible to the
entire cell surface, a different type of morphogenesis was
observed. Here, epimorphin induced formation of large
globular structures, which were surrounded by a single
layer of epithelial cells. Such “lumenal” structures, in con-
jugation with ducts, were reported previously for EpH4
Figure 9. Epimorphin production by transfectants in clonal cul-
tures leads to lumen formation. (A) The appearances of clusters
of PTSEd cultured in the presence (a) or absence (b–d) of 5 mg/ml
tetracycline, either for 8 d (a–c) or 14 d (d). Anti-epimorphin an-
tibodies (100 mg/ml) were added to medium in c. d9 is a section of
d stained with hematoxylin. Medium contained 50 ng/ml HGF in
each case. The appearance in c was often slightly different from a,
probably due to nonhomogeneous blocking of epimorphin trans-
gene by the antibodies, leading to some focal, polar presentation
of epimorphin outside the cluster. This is in turn would allow
some fine branching from the cluster mass (which nevertheless
did not resemble a branching phenotype). (B) Quantification of
the appearance of branching and lumenal phenotype of the trans-
fectants (The values indicate mean 6 SD of three separate exper-
iments). The concentration of the anti-epimorphin or mock anti-
bodies added to medium was 100 mg/ml. Bars, 200 mm.
Figure 8. Epimorphin expres-
sion and cellular growth in the
transfectants. (A) Character-
ization of transfectant clones
isolated and used in this
study: PTSEd, PTSEe (from
SCp2), and ETSEII (from
EpH4) expressed epimor-
phin transgene after removal
of tetracycline. PTSEa and
PTSEb cells were isolated
from SCp2 as controls. Note
that ETSEII was from an epi-
morphin-negative subpopula-
tion of EpH4 cells. (B) Immu-
noblot analysis of epimorphin
in the transfectants. The mo-
lecular mass of introduced
extracellular epimorphin was
37 kD, which was reduced to
that of endogenous epimor-
phin isoform I (34 kD) when
medium contained 0.02 and
0.1 mg/ml tunicamycin. (C) The growth ratios of PTSEa and
PTSEd cultured with or without tetracycline for 2 d. Media con-
taining 50 ng/ml HGF and EGF were also tested. Note that the
growth of transfected cells was severely suppressed when epimor-
phin transgene was induced (*).The Journal of Cell Biology, Volume 140, 1998 168
cells upon cultivation in collagen in the presence of EGF
(Oft et al., 1996), although no explanation for the diverse
morphology was offered at that time. We propose that epi-
morphin is capable of giving directional information: when
presented only to the periphery of cell clusters, it would
lead to focal lumen formation and branching as a gradient
is established, whereas exposure to the entire cell surface
would induce nondirectional radial growth and develop-
ment of spheres with a lumen.
The spheres that developed as a result of exposure to
epimorphin initially resembled mammary alveoli. How-
ever, with prolonged time in culture, the volume of spheres
dramatically increased, and structures began to resemble
large fluid-filled cysts, as are seen during gross cystic dis-
ease and pathological conditions of the mammary gland. It
is possible that during pathogenesis of the mammary gland,
alterations in ECM and disturbance of epithelial polarity
lead to accessibility of epimorphin to other than basal cell
surfaces, or that epithelial cells begin to express epimor-
phin themselves (as do EpH4 and other mammary cells in
culture). While these results do not prove whether epimor-
phin is involved in alveolar development during pregnancy
and lactation or cyst formation during pathological condi-
tions (or both), epimorphin appears to shape epithelial
morphogenesis by providing directional information.
The molecular mechanism by which epimorphin pro-
motes ductal branching and lumen formation remains to
be established. For endothelial cells, which undergo changes
in cellular architecture upon exposure to epimorphin in
three-dimensional collagen culture, it was found that epi-
morphin augmented expression of angiogenic factors in-
terleukin-8 and GM-CSF (Oka and Hirai, 1996). In the
same study, the ECM-degrading proteinase urokinase-
type plaminogen activator was upregulated by epimor-
phin. It is unlikely that in mammary cells epimorphin would
increase expression of growth factors which in turn could
stimulate branching in an autocrine or paracrine manner,
since proliferation was reduced in the presence of epimor-
phin. However, we found upregulation of gelatinase A
(not shown) when cells were maintained on an epimorphin
substratum. Gelatinase A may focally proteolyze ECM mole-
cules secreted by mammary epithelial cells and thereby alter
cell–substratum interactions or might initiate proteolytic
cascades that could result in degradation of type I collagen.
Epimorphin receptors have not yet been identified;
however, it was discovered that a 19–amino acid motif (NL-
peptide) within the H2 cell-binding domain of epimorphin
mediates binding of cells to epimorphin (Koshida and Hi-
rai, 1997). Furthermore, the NL-peptide perturbed mor-
phogenesis of embryonic lung as efficiently as function-
blocking antibodies to epimorphin. The identification of
the NL-peptide that functions in cell recognition also lends
further support to the notion that extracellular and not cy-
toplasmic epimorphin is the morphoregulatory form of
epimorphin. It remains unclear whether epimorphin inter-
acts with epithelial cells directly through binding to spe-
cific cell surface receptors or indirectly through binding of
other cell-associated molecules. One possibility is that epi-
morphin binds to ECM molecules that are secreted by epi-
thelial and mesenchymal cells such as laminins or type IV
collagen. In this context it is noteworthy that epimorphin
can be found in preparations of Engelbreth-Holm-Swarm
tumor matrix (Matrigel; Collaborative Biomedical Prod-
ucts, Waldham, MA; Hirai et al., 1993), which consists
mainly of basement membrane components laminin, en-
tactin/nidogen, type IV collagen, and heparan sulfate pro-
teoglycan (Kleinman et al., 1982). Interactions of epimor-
phin with ECM molecules could alter cellular function by
altering signaling through ECM receptors. Alternatively,
epimorphin itself may be involved in establishment of po-
larity, formation of an organized basement membrane, or
cell–cell junctional complexes. These possibilities are un-
der investigation.
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